Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Dongyuan Li
LncRNA PVT1 Facilitates Tumorigenesis and Progression of Glioma via Regulation of MiR-128-3p/GREM1 Axis and BMP Signaling Pathway
Neurotherapeutics
Neurology
Pharmacology
Theoretical Design of Porphyrin Sensitizers With Different Acceptors for Application in Dye-Sensitized Solar Cells
RSC Advances
Chemistry
Chemical Engineering
Related publications
LncRNA LINC01140 Inhibits Glioma Cell Migration and Invasion via Modulation of miR-199a-3p/ZHX1 Axis
OncoTargets and Therapy
Oncology
Pharmacology
LncRNA LOXL1‐AS1 Facilitates the Tumorigenesis and Stemness of Gastric Carcinoma via Regulation of miR‐708‐5p/USF1 Pathway
Cell Proliferation
Medicine
Cell Biology
LncRNA HULC Enhances Epithelial-Mesenchymal Transition to Promote Tumorigenesis and Metastasis of Hepatocellular Carcinoma via the miR-200a-3p/ZEB1 Signaling Pathway
Oncotarget
Oncology
Long Noncoding RNA SNHG17 Induced by YY1 Facilitates the Glioma Progression Through Targeting miR-506-3p/CTNNB1 Axis to Activate WNT/Β-Catenin Signaling Pathway
Cancer Cell International
Cancer Research
Oncology
Genetics
The Down-Regulation of lncRNA PCAT18 Promotes the Progression of Gastric Cancer via MiR-107/PTEN/PI3K/AKT Signaling Pathway
OncoTargets and Therapy
Oncology
Pharmacology
Knockdown of lncRNA PVT1 Alleviates High Glucose-Induced Proliferation and Fibrosis in Human Mesangial Cells by miR-23b-3p/WT1 Axis
Diabetology and Metabolic Syndrome
Internal Medicine
Endocrinology
Metabolism
Diabetes
LncRNA NEAT1 Enhances the Radio-Resistance of Cervical Cancer via miR-193b-3p/CCND1 Axis
Oncotarget
Oncology
Linc00152 Promotes Malignant Progression of Glioma Stem Cells by Regulating miR-103a-3p/FEZF1/CDC25A Pathway
Molecular Cancer
Cancer Research
Oncology
Molecular Medicine
Upregulated lncRNA SNHG1 Contributes to Progression of Non-Small Cell Lung Cancer Through Inhibition of miR-101-3p and Activation of WNT/Β-Catenin Signaling Pathway
Oncotarget
Oncology
